

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tricarboxylic acid metabolic process (GO:0072350) | 4.86591359 |
| 2 | lysine catabolic process (GO:0006554) | 4.80384509 |
| 3 | lysine metabolic process (GO:0006553) | 4.80384509 |
| 4 | valine metabolic process (GO:0006573) | 4.68766753 |
| 5 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.63669812 |
| 6 | 2-oxoglutarate metabolic process (GO:0006103) | 4.61981189 |
| 7 | establishment of integrated proviral latency (GO:0075713) | 4.46783778 |
| 8 | platelet dense granule organization (GO:0060155) | 4.40356661 |
| 9 | NADH metabolic process (GO:0006734) | 4.39863702 |
| 10 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.38563104 |
| 11 | phospholipid scrambling (GO:0017121) | 4.38537237 |
| 12 | tricarboxylic acid cycle (GO:0006099) | 4.33720964 |
| 13 | oxaloacetate metabolic process (GO:0006107) | 4.31265285 |
| 14 | DNA strand elongation (GO:0022616) | 4.28151494 |
| 15 | short-chain fatty acid metabolic process (GO:0046459) | 4.26370887 |
| 16 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.21269759 |
| 17 | DNA unwinding involved in DNA replication (GO:0006268) | 4.19725254 |
| 18 | carnitine shuttle (GO:0006853) | 4.03130230 |
| 19 | response to mercury ion (GO:0046689) | 4.02638059 |
| 20 | fatty acid beta-oxidation (GO:0006635) | 4.01766312 |
| 21 | aspartate family amino acid catabolic process (GO:0009068) | 3.99426081 |
| 22 | establishment of viral latency (GO:0019043) | 3.99051183 |
| 23 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.95345087 |
| 24 | L-phenylalanine metabolic process (GO:0006558) | 3.95345087 |
| 25 | succinate metabolic process (GO:0006105) | 3.93891831 |
| 26 | ethanol oxidation (GO:0006069) | 3.90091405 |
| 27 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.86313942 |
| 28 | ribosomal small subunit assembly (GO:0000028) | 3.84027567 |
| 29 | fatty acid catabolic process (GO:0009062) | 3.82449139 |
| 30 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.80609404 |
| 31 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.79110299 |
| 32 | fatty acid oxidation (GO:0019395) | 3.77725780 |
| 33 | branched-chain amino acid metabolic process (GO:0009081) | 3.75356359 |
| 34 | oxidative phosphorylation (GO:0006119) | 3.74293300 |
| 35 | branched-chain amino acid catabolic process (GO:0009083) | 3.73685483 |
| 36 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.73425226 |
| 37 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.73425226 |
| 38 | fatty acid transmembrane transport (GO:1902001) | 3.71556351 |
| 39 | lipid oxidation (GO:0034440) | 3.67762033 |
| 40 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.65048920 |
| 41 | L-phenylalanine catabolic process (GO:0006559) | 3.65048920 |
| 42 | protein localization to chromosome, centromeric region (GO:0071459) | 3.63944661 |
| 43 | mitotic chromosome condensation (GO:0007076) | 3.58083244 |
| 44 | CENP-A containing nucleosome assembly (GO:0034080) | 3.56397965 |
| 45 | telomere maintenance via recombination (GO:0000722) | 3.52641770 |
| 46 | DNA deamination (GO:0045006) | 3.51954666 |
| 47 | mitotic metaphase plate congression (GO:0007080) | 3.51943403 |
| 48 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.51262521 |
| 49 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.50729386 |
| 50 | cysteine metabolic process (GO:0006534) | 3.45522467 |
| 51 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.45209581 |
| 52 | chromatin remodeling at centromere (GO:0031055) | 3.44589152 |
| 53 | mitotic recombination (GO:0006312) | 3.43039398 |
| 54 | carnitine metabolic process (GO:0009437) | 3.42265390 |
| 55 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.41823224 |
| 56 | monocarboxylic acid catabolic process (GO:0072329) | 3.38503246 |
| 57 | negative regulation of ligase activity (GO:0051352) | 3.37836565 |
| 58 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.37836565 |
| 59 | ribosome assembly (GO:0042255) | 3.32724996 |
| 60 | regulation of fatty acid oxidation (GO:0046320) | 3.32213785 |
| 61 | amino-acid betaine metabolic process (GO:0006577) | 3.31754779 |
| 62 | carnitine transmembrane transport (GO:1902603) | 3.31651974 |
| 63 | amino-acid betaine transport (GO:0015838) | 3.31183925 |
| 64 | carnitine transport (GO:0015879) | 3.31183925 |
| 65 | viral transcription (GO:0019083) | 3.31160968 |
| 66 | respiratory electron transport chain (GO:0022904) | 3.28685940 |
| 67 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.28301634 |
| 68 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.28037559 |
| 69 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.27604093 |
| 70 | regulation of mitochondrial translation (GO:0070129) | 3.27438799 |
| 71 | glyoxylate metabolic process (GO:0046487) | 3.26652286 |
| 72 | proteasome assembly (GO:0043248) | 3.26257349 |
| 73 | protein localization to kinetochore (GO:0034501) | 3.25998627 |
| 74 | electron transport chain (GO:0022900) | 3.23945864 |
| 75 | deoxyribose phosphate catabolic process (GO:0046386) | 3.21511869 |
| 76 | DNA ligation (GO:0006266) | 3.21492710 |
| 77 | purine nucleobase biosynthetic process (GO:0009113) | 3.19123387 |
| 78 | deoxyribonucleotide catabolic process (GO:0009264) | 3.16711591 |
| 79 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.16482445 |
| 80 | mitotic sister chromatid segregation (GO:0000070) | 3.15013304 |
| 81 | acetyl-CoA metabolic process (GO:0006084) | 3.14266271 |
| 82 | translational termination (GO:0006415) | 3.14051148 |
| 83 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.10623062 |
| 84 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.08878531 |
| 85 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.07592655 |
| 86 | quaternary ammonium group transport (GO:0015697) | 3.06683513 |
| 87 | purine-containing compound salvage (GO:0043101) | 3.04927869 |
| 88 | pentose-phosphate shunt (GO:0006098) | 3.04836596 |
| 89 | sulfur amino acid catabolic process (GO:0000098) | 3.02920647 |
| 90 | drug transmembrane transport (GO:0006855) | 3.02079671 |
| 91 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.00946201 |
| 92 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.00273117 |
| 93 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.00273117 |
| 94 | IMP biosynthetic process (GO:0006188) | 2.98847488 |
| 95 | aerobic respiration (GO:0009060) | 2.98752208 |
| 96 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.98550863 |
| 97 | aromatic amino acid family catabolic process (GO:0009074) | 2.97794419 |
| 98 | regulation of oxidative phosphorylation (GO:0002082) | 2.97141075 |
| 99 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.96800993 |
| 100 | DNA replication initiation (GO:0006270) | 2.96694103 |
| 101 | IMP metabolic process (GO:0046040) | 2.95426328 |
| 102 | metaphase plate congression (GO:0051310) | 2.95035709 |
| 103 | regulation of cofactor metabolic process (GO:0051193) | 2.94725414 |
| 104 | regulation of coenzyme metabolic process (GO:0051196) | 2.94725414 |
| 105 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.94426192 |
| 106 | translational elongation (GO:0006414) | 2.93497570 |
| 107 | kynurenine metabolic process (GO:0070189) | 2.90261201 |
| 108 | negative regulation of chromosome segregation (GO:0051985) | 2.88636908 |
| 109 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.88161610 |
| 110 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.88155307 |
| 111 | ethanol metabolic process (GO:0006067) | 2.87982519 |
| 112 | kinetochore organization (GO:0051383) | 2.86279662 |
| 113 | muscle organ morphogenesis (GO:0048644) | 2.85878184 |
| 114 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.84845424 |
| 115 | negative regulation of sister chromatid segregation (GO:0033046) | 2.84845424 |
| 116 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.84845424 |
| 117 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.84845424 |
| 118 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.84845424 |
| 119 | pseudouridine synthesis (GO:0001522) | 2.84432804 |
| 120 | base-excision repair, AP site formation (GO:0006285) | 2.83920521 |
| 121 | purine nucleotide salvage (GO:0032261) | 2.82541383 |
| 122 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.82420995 |
| 123 | cellular modified amino acid catabolic process (GO:0042219) | 2.82333141 |
| 124 | carboxylic acid catabolic process (GO:0046395) | 2.82217703 |
| 125 | organic acid catabolic process (GO:0016054) | 2.82217703 |
| 126 | creatine metabolic process (GO:0006600) | 2.81825482 |
| 127 | formation of translation preinitiation complex (GO:0001731) | 2.81452597 |
| 128 | protein targeting to ER (GO:0045047) | 2.81278338 |
| 129 | sister chromatid segregation (GO:0000819) | 2.80762236 |
| 130 | mitotic spindle assembly checkpoint (GO:0007094) | 2.80181000 |
| 131 | nucleobase biosynthetic process (GO:0046112) | 2.80025124 |
| 132 | cellular ketone body metabolic process (GO:0046950) | 2.79624734 |
| 133 | DNA replication-independent nucleosome organization (GO:0034724) | 2.79388474 |
| 134 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.79388474 |
| 135 | cotranslational protein targeting to membrane (GO:0006613) | 2.79128201 |
| 136 | DNA replication checkpoint (GO:0000076) | 2.79056868 |
| 137 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.78242488 |
| 138 | spindle assembly checkpoint (GO:0071173) | 2.77904598 |
| 139 | alpha-linolenic acid metabolic process (GO:0036109) | 2.77108188 |
| 140 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.76238249 |
| 141 | protein deneddylation (GO:0000338) | 2.76141082 |
| 142 | phosphate ion transport (GO:0006817) | 2.74994933 |
| 143 | NADPH regeneration (GO:0006740) | 2.74992046 |
| 144 | homocysteine metabolic process (GO:0050667) | 2.74912442 |
| 145 | ribosomal small subunit biogenesis (GO:0042274) | 2.74833692 |
| 146 | bile acid biosynthetic process (GO:0006699) | 2.74737248 |
| 147 | glutamate metabolic process (GO:0006536) | 2.74596201 |
| 148 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.74168840 |
| 149 | folic acid metabolic process (GO:0046655) | 2.74121237 |
| 150 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.73878774 |
| 151 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.73757396 |
| 152 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.73421723 |
| 153 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.73247304 |
| 154 | cullin deneddylation (GO:0010388) | 2.72508227 |
| 155 | cellular amino acid catabolic process (GO:0009063) | 2.72196948 |
| 156 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.72148269 |
| 157 | telomere maintenance via telomere lengthening (GO:0010833) | 2.71458100 |
| 158 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.71213983 |
| 159 | protein localization to endoplasmic reticulum (GO:0070972) | 2.71210528 |
| 160 | deoxyribose phosphate metabolic process (GO:0019692) | 2.70883395 |
| 161 | base-excision repair (GO:0006284) | 2.70827817 |
| 162 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.70570193 |
| 163 | alpha-amino acid catabolic process (GO:1901606) | 2.70049956 |
| 164 | deoxyribonucleotide metabolic process (GO:0009262) | 2.69586659 |
| 165 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.69257609 |
| 166 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.69257609 |
| 167 | positive regulation of ligase activity (GO:0051351) | 2.68868155 |
| 168 | establishment of chromosome localization (GO:0051303) | 2.68513568 |
| 169 | pinocytosis (GO:0006907) | 2.68250609 |
| 170 | metallo-sulfur cluster assembly (GO:0031163) | 2.68173953 |
| 171 | iron-sulfur cluster assembly (GO:0016226) | 2.68173953 |
| 172 | spindle checkpoint (GO:0031577) | 2.67577206 |
| 173 | mitochondrial calcium ion transport (GO:0006851) | 2.66970569 |
| 174 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.66582764 |
| 175 | regulation of ligase activity (GO:0051340) | 2.66230295 |
| 176 | drug transport (GO:0015893) | 2.66017370 |
| 177 | 4-hydroxyproline metabolic process (GO:0019471) | 2.65994600 |
| 178 | protein maturation by protein folding (GO:0022417) | 2.65346235 |
| 179 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.65101700 |
| 180 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.64492069 |
| 181 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.63652434 |
| 182 | regulation of sulfur metabolic process (GO:0042762) | 2.62671413 |
| 183 | nucleoside salvage (GO:0043174) | 2.62271274 |
| 184 | dicarboxylic acid metabolic process (GO:0043648) | 2.61113204 |
| 185 | regulation of chromosome segregation (GO:0051983) | 2.60627105 |
| 186 | gluconeogenesis (GO:0006094) | 2.60450289 |
| 187 | mitotic spindle checkpoint (GO:0071174) | 2.59697473 |
| 188 | flavonoid metabolic process (GO:0009812) | 2.59176446 |
| 189 | nucleotide salvage (GO:0043173) | 2.57724420 |
| 190 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.57683875 |
| 191 | ATP synthesis coupled proton transport (GO:0015986) | 2.57683875 |
| 192 | biotin metabolic process (GO:0006768) | 2.54699669 |
| 193 | primary alcohol catabolic process (GO:0034310) | 2.54255754 |
| 194 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.53112113 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.75966308 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.51852592 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.09143368 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 4.30778341 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.76826468 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.51851638 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.40954091 |
| 8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.40259484 |
| 9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.21636105 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.20411858 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.98433931 |
| 12 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.95575760 |
| 13 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.94898364 |
| 14 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.89785036 |
| 15 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.83805790 |
| 16 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.66738626 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.56210247 |
| 18 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.51975852 |
| 19 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.49447241 |
| 20 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.48340982 |
| 21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.34482504 |
| 22 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.33959948 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.30869265 |
| 24 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.29440155 |
| 25 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.28770601 |
| 26 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.23718450 |
| 27 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.22082572 |
| 28 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.15368788 |
| 29 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.12188110 |
| 30 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.11741935 |
| 31 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.09401667 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09350942 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.06378485 |
| 34 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.04925991 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.97654740 |
| 36 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.95088224 |
| 37 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.90785244 |
| 38 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.90018801 |
| 39 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.87719074 |
| 40 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87125187 |
| 41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84061569 |
| 42 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.82055603 |
| 43 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.81165433 |
| 44 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.80498283 |
| 45 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.75687664 |
| 46 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.75632949 |
| 47 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.75462985 |
| 48 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75402783 |
| 49 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.71690231 |
| 50 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.71270168 |
| 51 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.70995539 |
| 52 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.68190687 |
| 53 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.60557120 |
| 54 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.59032871 |
| 55 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.56251279 |
| 56 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.56096231 |
| 57 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.54634604 |
| 58 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.53559489 |
| 59 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.53476772 |
| 60 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.53023961 |
| 61 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.52080556 |
| 62 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50707809 |
| 63 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.50485552 |
| 64 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.48708356 |
| 65 | MYC_22102868_ChIP-Seq_BL_Human | 1.48513128 |
| 66 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.47084338 |
| 67 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.45807488 |
| 68 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.45007271 |
| 69 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.44404410 |
| 70 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.41456976 |
| 71 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.38215533 |
| 72 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.36383597 |
| 73 | P68_20966046_ChIP-Seq_HELA_Human | 1.36351325 |
| 74 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.35245300 |
| 75 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.34246234 |
| 76 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.33349168 |
| 77 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.33128939 |
| 78 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.32820333 |
| 79 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.32745520 |
| 80 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.32554889 |
| 81 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.32400679 |
| 82 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.32220117 |
| 83 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.31894804 |
| 84 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29452665 |
| 85 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.29447689 |
| 86 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.29414807 |
| 87 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.28160303 |
| 88 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.27764024 |
| 89 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.26914049 |
| 90 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26570044 |
| 91 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.26449750 |
| 92 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.26335370 |
| 93 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.23944600 |
| 94 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.23439355 |
| 95 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.23270035 |
| 96 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.21507091 |
| 97 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.20988543 |
| 98 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.19676177 |
| 99 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.19579047 |
| 100 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.19155555 |
| 101 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.18639222 |
| 102 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.17955249 |
| 103 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16907883 |
| 104 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.16889901 |
| 105 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.16323806 |
| 106 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.14230166 |
| 107 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.12070173 |
| 108 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.12058457 |
| 109 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.11135301 |
| 110 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09876109 |
| 111 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.09485430 |
| 112 | P300_27268052_Chip-Seq_Bcells_Human | 1.09339562 |
| 113 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.09179835 |
| 114 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.08990678 |
| 115 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08825914 |
| 116 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.08216744 |
| 117 | SA1_27219007_Chip-Seq_Bcells_Human | 1.07336874 |
| 118 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.07224575 |
| 119 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05826090 |
| 120 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05331936 |
| 121 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03812844 |
| 122 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03641333 |
| 123 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.03012214 |
| 124 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.03005744 |
| 125 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.02806031 |
| 126 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.01758027 |
| 127 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01732854 |
| 128 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.98800663 |
| 129 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.97976596 |
| 130 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.97767659 |
| 131 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.97739993 |
| 132 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.97295637 |
| 133 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.96824048 |
| 134 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96192051 |
| 135 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.95973686 |
| 136 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.95273008 |
| 137 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.95122098 |
| 138 | MAF_26560356_Chip-Seq_TH1_Human | 0.94693015 |
| 139 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.93997088 |
| 140 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.92590367 |
| 141 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.92018212 |
| 142 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.92012244 |
| 143 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.92012244 |
| 144 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.91648671 |
| 145 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.91304299 |
| 146 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.91210635 |
| 147 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.90888774 |
| 148 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.89237622 |
| 149 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.89011119 |
| 150 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88954170 |
| 151 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.87954095 |
| 152 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.87700399 |
| 153 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.87610758 |
| 154 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.87571657 |
| 155 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.87124761 |
| 156 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.86908665 |
| 157 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.86900993 |
| 158 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86336062 |
| 159 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86106768 |
| 160 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.85803211 |
| 161 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.84842712 |
| 162 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.84726404 |
| 163 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.84666101 |
| 164 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.84629470 |
| 165 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.84519291 |
| 166 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.83738884 |
| 167 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.83423390 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010094_abnormal_chromosome_stability | 3.95445365 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.68964330 |
| 3 | MP0005360_urolithiasis | 3.67015177 |
| 4 | MP0003111_abnormal_nucleus_morphology | 3.65926182 |
| 5 | MP0003693_abnormal_embryo_hatching | 3.51758480 |
| 6 | MP0005365_abnormal_bile_salt | 3.50144444 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 3.40060580 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 3.23910040 |
| 9 | MP0004957_abnormal_blastocyst_morpholog | 3.20781151 |
| 10 | MP0002877_abnormal_melanocyte_morpholog | 3.00175305 |
| 11 | MP0008058_abnormal_DNA_repair | 2.97100259 |
| 12 | MP0003646_muscle_fatigue | 2.96674544 |
| 13 | MP0008057_abnormal_DNA_replication | 2.92656750 |
| 14 | MP0003077_abnormal_cell_cycle | 2.86255056 |
| 15 | MP0006036_abnormal_mitochondrial_physio | 2.85582244 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 2.68419994 |
| 17 | MP0000751_myopathy | 2.64810876 |
| 18 | MP0008875_abnormal_xenobiotic_pharmacok | 2.47430463 |
| 19 | MP0004130_abnormal_muscle_cell | 2.44636109 |
| 20 | MP0008932_abnormal_embryonic_tissue | 2.34614299 |
| 21 | MP0000749_muscle_degeneration | 2.34573108 |
| 22 | MP0008007_abnormal_cellular_replicative | 2.28922422 |
| 23 | MP0003252_abnormal_bile_duct | 2.23241991 |
| 24 | MP0005330_cardiomyopathy | 2.22516939 |
| 25 | MP0004147_increased_porphyrin_level | 2.18765143 |
| 26 | MP0010329_abnormal_lipoprotein_level | 2.15895365 |
| 27 | MP0004215_abnormal_myocardial_fiber | 2.15421548 |
| 28 | MP0005083_abnormal_biliary_tract | 2.09767523 |
| 29 | MP0001666_abnormal_nutrient_absorption | 2.00677423 |
| 30 | MP0005332_abnormal_amino_acid | 2.00024652 |
| 31 | MP0005058_abnormal_lysosome_morphology | 1.95306967 |
| 32 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.94130158 |
| 33 | MP0000747_muscle_weakness | 1.87970289 |
| 34 | MP0004145_abnormal_muscle_electrophysio | 1.84506844 |
| 35 | MP0005451_abnormal_body_composition | 1.78171019 |
| 36 | MP0004043_abnormal_pH_regulation | 1.76033200 |
| 37 | MP0008961_abnormal_basal_metabolism | 1.73385583 |
| 38 | MP0003786_premature_aging | 1.70144813 |
| 39 | MP0004036_abnormal_muscle_relaxation | 1.69026800 |
| 40 | MP0001873_stomach_inflammation | 1.68553660 |
| 41 | MP0004084_abnormal_cardiac_muscle | 1.62713173 |
| 42 | MP0002118_abnormal_lipid_homeostasis | 1.61152793 |
| 43 | MP0002269_muscular_atrophy | 1.54592434 |
| 44 | MP0005535_abnormal_body_temperature | 1.53070627 |
| 45 | MP0000350_abnormal_cell_proliferation | 1.52772820 |
| 46 | MP0005319_abnormal_enzyme/_coenzyme | 1.51171358 |
| 47 | MP0006035_abnormal_mitochondrial_morpho | 1.50771399 |
| 48 | MP0002332_abnormal_exercise_endurance | 1.48934255 |
| 49 | MP0009643_abnormal_urine_homeostasis | 1.48906752 |
| 50 | MP0005266_abnormal_metabolism | 1.45679008 |
| 51 | MP0004859_abnormal_synaptic_plasticity | 1.44685531 |
| 52 | MP0008260_abnormal_autophagy | 1.43764689 |
| 53 | MP0004087_abnormal_muscle_fiber | 1.42251275 |
| 54 | MP0003868_abnormal_feces_composition | 1.42210961 |
| 55 | MP0000750_abnormal_muscle_regeneration | 1.41229517 |
| 56 | MP0000313_abnormal_cell_death | 1.40707060 |
| 57 | MP0010307_abnormal_tumor_latency | 1.39357803 |
| 58 | MP0005220_abnormal_exocrine_pancreas | 1.38542140 |
| 59 | MP0001730_embryonic_growth_arrest | 1.37493251 |
| 60 | MP0002909_abnormal_adrenal_gland | 1.35568749 |
| 61 | MP0005666_abnormal_adipose_tissue | 1.35429268 |
| 62 | MP0003221_abnormal_cardiomyocyte_apopto | 1.35237389 |
| 63 | MP0001853_heart_inflammation | 1.34824887 |
| 64 | MP0002078_abnormal_glucose_homeostasis | 1.34343313 |
| 65 | MP0005636_abnormal_mineral_homeostasis | 1.34160531 |
| 66 | MP0005501_abnormal_skin_physiology | 1.32420740 |
| 67 | MP0001765_abnormal_ion_homeostasis | 1.31186991 |
| 68 | MP0000609_abnormal_liver_physiology | 1.30439097 |
| 69 | MP0005620_abnormal_muscle_contractility | 1.29152984 |
| 70 | MP0001764_abnormal_homeostasis | 1.27081717 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 1.26067087 |
| 72 | MP0001835_abnormal_antigen_presentation | 1.24908471 |
| 73 | MP0000490_abnormal_crypts_of | 1.24754086 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 1.24292393 |
| 75 | MP0009333_abnormal_splenocyte_physiolog | 1.23028118 |
| 76 | MP0002019_abnormal_tumor_incidence | 1.22317699 |
| 77 | MP0000358_abnormal_cell_content/ | 1.22168398 |
| 78 | MP0004808_abnormal_hematopoietic_stem | 1.21644585 |
| 79 | MP0009840_abnormal_foam_cell | 1.21124180 |
| 80 | MP0003191_abnormal_cellular_cholesterol | 1.20330551 |
| 81 | MP0003186_abnormal_redox_activity | 1.19480263 |
| 82 | MP0001727_abnormal_embryo_implantation | 1.19213431 |
| 83 | MP0009278_abnormal_bone_marrow | 1.17793356 |
| 84 | MP0009379_abnormal_foot_pigmentation | 1.16639965 |
| 85 | MP0010352_gastrointestinal_tract_polyps | 1.14053933 |
| 86 | MP0002822_catalepsy | 1.13955468 |
| 87 | MP0001348_abnormal_lacrimal_gland | 1.13040372 |
| 88 | MP0003718_maternal_effect | 1.11662663 |
| 89 | MP0003195_calcinosis | 1.10908933 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 1.10862935 |
| 91 | MP0004484_altered_response_of | 1.10693907 |
| 92 | MP0009697_abnormal_copulation | 1.10599867 |
| 93 | MP0008872_abnormal_physiological_respon | 1.10020113 |
| 94 | MP0002971_abnormal_brown_adipose | 1.10015130 |
| 95 | MP0005375_adipose_tissue_phenotype | 1.09885561 |
| 96 | MP0000343_altered_response_to | 1.09162570 |
| 97 | MP0002396_abnormal_hematopoietic_system | 1.09156851 |
| 98 | MP0005165_increased_susceptibility_to | 1.08784764 |
| 99 | MP0003315_abnormal_perineum_morphology | 1.08642233 |
| 100 | MP0001545_abnormal_hematopoietic_system | 1.08348588 |
| 101 | MP0005397_hematopoietic_system_phenotyp | 1.08348588 |
| 102 | MP0005084_abnormal_gallbladder_morpholo | 1.08108094 |
| 103 | MP0001661_extended_life_span | 1.07987028 |
| 104 | MP0002106_abnormal_muscle_physiology | 1.05100187 |
| 105 | MP0004510_myositis | 1.04855144 |
| 106 | MP0000013_abnormal_adipose_tissue | 1.04551356 |
| 107 | MP0001697_abnormal_embryo_size | 1.04421407 |
| 108 | MP0010234_abnormal_vibrissa_follicle | 1.04203957 |
| 109 | MP0002796_impaired_skin_barrier | 1.03987112 |
| 110 | MP0002148_abnormal_hypersensitivity_rea | 1.03819475 |
| 111 | MP0000858_altered_metastatic_potential | 1.03144214 |
| 112 | MP0010630_abnormal_cardiac_muscle | 1.03084501 |
| 113 | MP0002080_prenatal_lethality | 1.02588732 |
| 114 | MP0002972_abnormal_cardiac_muscle | 1.00026998 |
| 115 | MP0003828_pulmonary_edema | 0.99672054 |
| 116 | MP0008775_abnormal_heart_ventricle | 0.97662439 |
| 117 | MP0008874_decreased_physiological_sensi | 0.97569638 |
| 118 | MP0005076_abnormal_cell_differentiation | 0.96557050 |
| 119 | MP0005670_abnormal_white_adipose | 0.96494604 |
| 120 | MP0001881_abnormal_mammary_gland | 0.96359819 |
| 121 | MP0005380_embryogenesis_phenotype | 0.96323093 |
| 122 | MP0001672_abnormal_embryogenesis/_devel | 0.96323093 |
| 123 | MP0003436_decreased_susceptibility_to | 0.96318309 |
| 124 | MP0001944_abnormal_pancreas_morphology | 0.95089841 |
| 125 | MP0003941_abnormal_skin_development | 0.93684434 |
| 126 | MP0005334_abnormal_fat_pad | 0.93012830 |
| 127 | MP0000759_abnormal_skeletal_muscle | 0.92932599 |
| 128 | MP0003075_altered_response_to | 0.92661418 |
| 129 | MP0003137_abnormal_impulse_conducting | 0.92318585 |
| 130 | MP0000003_abnormal_adipose_tissue | 0.90943111 |
| 131 | MP0002693_abnormal_pancreas_physiology | 0.89833292 |
| 132 | MP0003984_embryonic_growth_retardation | 0.89634538 |
| 133 | MP0009765_abnormal_xenobiotic_induced | 0.89177539 |
| 134 | MP0000230_abnormal_systemic_arterial | 0.88001760 |
| 135 | MP0002419_abnormal_innate_immunity | 0.85381966 |
| 136 | MP0002722_abnormal_immune_system | 0.84967094 |
| 137 | MP0005464_abnormal_platelet_physiology | 0.84133475 |
| 138 | MP0005385_cardiovascular_system_phenoty | 0.84030127 |
| 139 | MP0001544_abnormal_cardiovascular_syste | 0.84030127 |
| 140 | MP0002088_abnormal_embryonic_growth/wei | 0.83811519 |
| 141 | MP0000689_abnormal_spleen_morphology | 0.82749842 |
| 142 | MP0009642_abnormal_blood_homeostasis | 0.82609246 |
| 143 | MP0004233_abnormal_muscle_weight | 0.81885941 |
| 144 | MP0005376_homeostasis/metabolism_phenot | 0.81548989 |
| 145 | MP0005448_abnormal_energy_balance | 0.80144486 |
| 146 | MP0003566_abnormal_cell_adhesion | 0.80096989 |
| 147 | MP0002970_abnormal_white_adipose | 0.79880770 |
| 148 | MP0001663_abnormal_digestive_system | 0.79720792 |
| 149 | MP0005384_cellular_phenotype | 0.78766779 |
| 150 | MP0003959_abnormal_lean_body | 0.77810018 |
| 151 | MP0005621_abnormal_cell_physiology | 0.77362252 |
| 152 | MP0009764_decreased_sensitivity_to | 0.76135841 |
| 153 | MP0003879_abnormal_hair_cell | 0.75963464 |
| 154 | MP0002166_altered_tumor_susceptibility | 0.75693350 |
| 155 | MP0002398_abnormal_bone_marrow | 0.73179107 |
| 156 | MP0001542_abnormal_bone_strength | 0.73124928 |
| 157 | MP0004185_abnormal_adipocyte_glucose | 0.72455677 |
| 158 | MP0002429_abnormal_blood_cell | 0.72358289 |
| 159 | MP0009763_increased_sensitivity_to | 0.72026593 |
| 160 | MP0005369_muscle_phenotype | 0.71367927 |
| 161 | MP0008469_abnormal_protein_level | 0.69102608 |
| 162 | MP0001243_abnormal_dermal_layer | 0.67642485 |
| 163 | MP0002452_abnormal_antigen_presenting | 0.66777716 |
| 164 | MP0000015_abnormal_ear_pigmentation | 0.66711774 |
| 165 | MP0003705_abnormal_hypodermis_morpholog | 0.66200706 |
| 166 | MP0005025_abnormal_response_to | 0.65980322 |
| 167 | MP0003303_peritoneal_inflammation | 0.65240535 |
| 168 | MP0002009_preneoplasia | 0.65082122 |
| 169 | MP0001191_abnormal_skin_condition | 0.64752419 |
| 170 | MP0000569_abnormal_digit_pigmentation | 0.64723627 |
| 171 | MP0004197_abnormal_fetal_growth/weight/ | 0.64608412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 4.54017221 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 4.18550964 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.09595963 |
| 4 | Ketoacidosis (HP:0001993) | 3.80753717 |
| 5 | * Myoglobinuria (HP:0002913) | 3.77699435 |
| 6 | Ketosis (HP:0001946) | 3.73783666 |
| 7 | Hypoglycemic coma (HP:0001325) | 3.68486247 |
| 8 | Hepatic necrosis (HP:0002605) | 3.57932900 |
| 9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.55761472 |
| 10 | Abnormality of alanine metabolism (HP:0010916) | 3.52779302 |
| 11 | Hyperalaninemia (HP:0003348) | 3.52779302 |
| 12 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.52779302 |
| 13 | Reduced antithrombin III activity (HP:0001976) | 3.33642437 |
| 14 | Exercise-induced myalgia (HP:0003738) | 3.26322314 |
| 15 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.25027847 |
| 16 | Hyperammonemia (HP:0001987) | 3.22962244 |
| 17 | Dicarboxylic aciduria (HP:0003215) | 3.20708510 |
| 18 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.20708510 |
| 19 | Hepatocellular necrosis (HP:0001404) | 3.16636556 |
| 20 | Type I transferrin isoform profile (HP:0003642) | 3.10237076 |
| 21 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.07099504 |
| 22 | Acute encephalopathy (HP:0006846) | 3.01799157 |
| 23 | Increased muscle lipid content (HP:0009058) | 2.99594611 |
| 24 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.99528221 |
| 25 | Abnormal number of erythroid precursors (HP:0012131) | 2.98313643 |
| 26 | Microvesicular hepatic steatosis (HP:0001414) | 2.97507131 |
| 27 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.93393212 |
| 28 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.93293827 |
| 29 | Calf muscle hypertrophy (HP:0008981) | 2.91711325 |
| 30 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.91154347 |
| 31 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.91154347 |
| 32 | Abnormal protein glycosylation (HP:0012346) | 2.91154347 |
| 33 | Abnormal glycosylation (HP:0012345) | 2.91154347 |
| 34 | Dry hair (HP:0011359) | 2.87751628 |
| 35 | Cerebral edema (HP:0002181) | 2.86422129 |
| 36 | Prostate neoplasm (HP:0100787) | 2.86229054 |
| 37 | Palpitations (HP:0001962) | 2.81327030 |
| 38 | Rhabdomyolysis (HP:0003201) | 2.77549814 |
| 39 | Acute necrotizing encephalopathy (HP:0006965) | 2.76494629 |
| 40 | * Lactic acidosis (HP:0003128) | 2.74849614 |
| 41 | Hyperglycinuria (HP:0003108) | 2.74435122 |
| 42 | Generalized aminoaciduria (HP:0002909) | 2.74028022 |
| 43 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.73342957 |
| 44 | Rough bone trabeculation (HP:0100670) | 2.73094235 |
| 45 | * Ragged-red muscle fibers (HP:0003200) | 2.71967205 |
| 46 | Abnormality of glycine metabolism (HP:0010895) | 2.70195301 |
| 47 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.70195301 |
| 48 | Selective tooth agenesis (HP:0001592) | 2.69935174 |
| 49 | Sudden death (HP:0001699) | 2.69722883 |
| 50 | Hepatosplenomegaly (HP:0001433) | 2.69255195 |
| 51 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.67619079 |
| 52 | Exercise-induced muscle cramps (HP:0003710) | 2.67291975 |
| 53 | Asymmetric septal hypertrophy (HP:0001670) | 2.65155831 |
| 54 | Metabolic acidosis (HP:0001942) | 2.64021163 |
| 55 | Atrioventricular block (HP:0001678) | 2.62858243 |
| 56 | Increased intramyocellular lipid droplets (HP:0012240) | 2.60187715 |
| 57 | Increased CSF lactate (HP:0002490) | 2.59590834 |
| 58 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.59297841 |
| 59 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.59297841 |
| 60 | Multiple enchondromatosis (HP:0005701) | 2.58882494 |
| 61 | Late onset (HP:0003584) | 2.57385588 |
| 62 | Increased serum pyruvate (HP:0003542) | 2.56260787 |
| 63 | Petechiae (HP:0000967) | 2.55679434 |
| 64 | Mitochondrial inheritance (HP:0001427) | 2.52794290 |
| 65 | Delayed CNS myelination (HP:0002188) | 2.51529348 |
| 66 | Rimmed vacuoles (HP:0003805) | 2.51059288 |
| 67 | Bundle branch block (HP:0011710) | 2.50911559 |
| 68 | Nasal polyposis (HP:0100582) | 2.50888119 |
| 69 | Gout (HP:0001997) | 2.50510327 |
| 70 | Myopathic facies (HP:0002058) | 2.49877011 |
| 71 | Xanthomatosis (HP:0000991) | 2.44746074 |
| 72 | Ventricular tachycardia (HP:0004756) | 2.43466159 |
| 73 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.42685463 |
| 74 | Abnormality of the anterior horn cell (HP:0006802) | 2.41711520 |
| 75 | Degeneration of anterior horn cells (HP:0002398) | 2.41711520 |
| 76 | Hyperglycinemia (HP:0002154) | 2.41133890 |
| 77 | Neck muscle weakness (HP:0000467) | 2.40691794 |
| 78 | Intrahepatic cholestasis (HP:0001406) | 2.40574144 |
| 79 | Hyperlipoproteinemia (HP:0010980) | 2.38772248 |
| 80 | Heart block (HP:0012722) | 2.37102828 |
| 81 | Abnormality of the nasal mucosa (HP:0000433) | 2.34787186 |
| 82 | Thrombocytosis (HP:0001894) | 2.32699793 |
| 83 | Increased serum lactate (HP:0002151) | 2.30708693 |
| 84 | Aplastic anemia (HP:0001915) | 2.29448487 |
| 85 | Abnormality of glycolysis (HP:0004366) | 2.24915969 |
| 86 | Lethargy (HP:0001254) | 2.23511418 |
| 87 | Distal lower limb muscle weakness (HP:0009053) | 2.23205862 |
| 88 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.22535518 |
| 89 | Right ventricular cardiomyopathy (HP:0011663) | 2.20645572 |
| 90 | Abnormality of the prostate (HP:0008775) | 2.19294547 |
| 91 | Progressive macrocephaly (HP:0004481) | 2.15973771 |
| 92 | Myotonia (HP:0002486) | 2.14374335 |
| 93 | Hypokinesia (HP:0002375) | 2.13797967 |
| 94 | Abnormality of serum amino acid levels (HP:0003112) | 2.13479779 |
| 95 | Hyperbilirubinemia (HP:0002904) | 2.13195429 |
| 96 | Abnormality of the umbilical cord (HP:0010881) | 2.13090754 |
| 97 | * Progressive muscle weakness (HP:0003323) | 2.12047817 |
| 98 | Abnormal atrioventricular conduction (HP:0005150) | 2.11452020 |
| 99 | Supraventricular tachycardia (HP:0004755) | 2.10200231 |
| 100 | Vomiting (HP:0002013) | 2.10090589 |
| 101 | Abnormal trabecular bone morphology (HP:0100671) | 2.08656776 |
| 102 | Atrial fibrillation (HP:0005110) | 2.07318473 |
| 103 | Type II lissencephaly (HP:0007260) | 2.07022775 |
| 104 | * Pancytopenia (HP:0001876) | 2.05128042 |
| 105 | Chromsome breakage (HP:0040012) | 2.04726792 |
| 106 | Supraventricular arrhythmia (HP:0005115) | 2.04067231 |
| 107 | Methylmalonic aciduria (HP:0012120) | 2.03903658 |
| 108 | Pelvic girdle muscle weakness (HP:0003749) | 2.03617832 |
| 109 | Ridged nail (HP:0001807) | 2.03239030 |
| 110 | Recurrent bacterial skin infections (HP:0005406) | 2.03113195 |
| 111 | Recurrent abscess formation (HP:0002722) | 2.01075610 |
| 112 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.00491645 |
| 113 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.00491645 |
| 114 | Abnormality of glycolipid metabolism (HP:0010969) | 2.00491645 |
| 115 | Shoulder girdle muscle weakness (HP:0003547) | 1.99331615 |
| 116 | Primary atrial arrhythmia (HP:0001692) | 1.98899297 |
| 117 | EMG: myopathic abnormalities (HP:0003458) | 1.98537340 |
| 118 | Lipoatrophy (HP:0100578) | 1.97472328 |
| 119 | Limb-girdle muscle atrophy (HP:0003797) | 1.96959498 |
| 120 | Fatigue (HP:0012378) | 1.96546343 |
| 121 | Deep venous thrombosis (HP:0002625) | 1.96167526 |
| 122 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.95781168 |
| 123 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.95369323 |
| 124 | Abnormality of the intrinsic pathway (HP:0010989) | 1.95206727 |
| 125 | Nausea (HP:0002018) | 1.94963761 |
| 126 | Neoplasm of the adrenal gland (HP:0100631) | 1.94582455 |
| 127 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.94060039 |
| 128 | Cortical dysplasia (HP:0002539) | 1.92837487 |
| 129 | Proximal tubulopathy (HP:0000114) | 1.92702365 |
| 130 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.92429365 |
| 131 | Sparse eyelashes (HP:0000653) | 1.91635159 |
| 132 | Exercise intolerance (HP:0003546) | 1.91040930 |
| 133 | Hypobetalipoproteinemia (HP:0003563) | 1.90048917 |
| 134 | Dilated cardiomyopathy (HP:0001644) | 1.88408587 |
| 135 | Prolonged partial thromboplastin time (HP:0003645) | 1.88027992 |
| 136 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.88005640 |
| 137 | Subaortic stenosis (HP:0001682) | 1.88005640 |
| 138 | Impaired platelet aggregation (HP:0003540) | 1.87842541 |
| 139 | Abnormal platelet function (HP:0011869) | 1.87842541 |
| 140 | Increased hepatocellular lipid droplets (HP:0006565) | 1.87600601 |
| 141 | Esophageal neoplasm (HP:0100751) | 1.86008021 |
| 142 | Neoplasm of head and neck (HP:0012288) | 1.86008021 |
| 143 | Lipid accumulation in hepatocytes (HP:0006561) | 1.85798225 |
| 144 | Abnormality of purine metabolism (HP:0004352) | 1.85401977 |
| 145 | Muscle stiffness (HP:0003552) | 1.84233694 |
| 146 | Syncope (HP:0001279) | 1.84064567 |
| 147 | Paralysis (HP:0003470) | 1.83753152 |
| 148 | Fasciculations (HP:0002380) | 1.83138452 |
| 149 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.81796017 |
| 150 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.80720747 |
| 151 | Respiratory failure (HP:0002878) | 1.79770618 |
| 152 | Ventricular arrhythmia (HP:0004308) | 1.78511900 |
| 153 | Pancreatitis (HP:0001733) | 1.76799061 |
| 154 | Orthostatic hypotension (HP:0001278) | 1.76109673 |
| 155 | Increased serum ferritin (HP:0003281) | 1.75980799 |
| 156 | Abnormality of the calf musculature (HP:0001430) | 1.75844321 |
| 157 | Hyperuricemia (HP:0002149) | 1.75712992 |
| 158 | Increased purine levels (HP:0004368) | 1.75712992 |
| 159 | Sensorimotor neuropathy (HP:0007141) | 1.75054620 |
| 160 | Calcaneovalgus deformity (HP:0001848) | 1.74079676 |
| 161 | Microretrognathia (HP:0000308) | 1.72817522 |
| 162 | Gliosis (HP:0002171) | 1.72522963 |
| 163 | Abnormality of the preputium (HP:0100587) | 1.72361990 |
| 164 | Entropion (HP:0000621) | 1.70181297 |
| 165 | Vertebral compression fractures (HP:0002953) | 1.69631302 |
| 166 | Upper motor neuron abnormality (HP:0002127) | 1.69331982 |
| 167 | Myelodysplasia (HP:0002863) | 1.66778316 |
| 168 | Type 1 muscle fiber predominance (HP:0003803) | 1.63502146 |
| 169 | Abnormality of lateral ventricle (HP:0030047) | 1.63491899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.54659774 |
| 2 | BUB1 | 4.20911182 |
| 3 | CDC7 | 3.39907872 |
| 4 | PKN2 | 3.17345235 |
| 5 | TESK2 | 3.17021415 |
| 6 | PINK1 | 3.04122908 |
| 7 | SRPK1 | 2.96104575 |
| 8 | VRK2 | 2.94337555 |
| 9 | TRIB3 | 2.84363455 |
| 10 | PBK | 2.81251457 |
| 11 | TTK | 2.40929411 |
| 12 | PDK2 | 2.40142109 |
| 13 | IRAK3 | 2.38637050 |
| 14 | ERN1 | 2.27313164 |
| 15 | EIF2AK1 | 2.04296270 |
| 16 | NME2 | 2.04027512 |
| 17 | MAP2K3 | 2.00184625 |
| 18 | TTN | 1.89463724 |
| 19 | MUSK | 1.88382782 |
| 20 | PLK4 | 1.87182197 |
| 21 | FLT3 | 1.78344469 |
| 22 | MAP3K7 | 1.77144643 |
| 23 | CCNB1 | 1.74917567 |
| 24 | MAP3K12 | 1.72174210 |
| 25 | TNIK | 1.70522878 |
| 26 | EEF2K | 1.67194456 |
| 27 | LMTK2 | 1.66121981 |
| 28 | MYLK | 1.65772971 |
| 29 | ARAF | 1.63555391 |
| 30 | KSR2 | 1.61809181 |
| 31 | CDK19 | 1.58827999 |
| 32 | PDK3 | 1.58552523 |
| 33 | PDK4 | 1.58552523 |
| 34 | MAP3K13 | 1.57438013 |
| 35 | MAPKAPK3 | 1.54100836 |
| 36 | NEK1 | 1.53775592 |
| 37 | CAMKK2 | 1.44690754 |
| 38 | TIE1 | 1.43691496 |
| 39 | RPS6KA4 | 1.43374712 |
| 40 | STK16 | 1.43004282 |
| 41 | PHKG2 | 1.39522461 |
| 42 | PHKG1 | 1.39522461 |
| 43 | RAF1 | 1.38303045 |
| 44 | PLK1 | 1.37610119 |
| 45 | RIPK1 | 1.34426907 |
| 46 | TESK1 | 1.30066386 |
| 47 | OBSCN | 1.28049122 |
| 48 | PAK4 | 1.21687070 |
| 49 | VRK1 | 1.19927897 |
| 50 | LIMK1 | 1.19845454 |
| 51 | PIM2 | 1.19183296 |
| 52 | ABL2 | 1.18271868 |
| 53 | STK10 | 1.17579871 |
| 54 | DAPK1 | 1.16796869 |
| 55 | AURKA | 1.13805625 |
| 56 | AURKB | 1.13244989 |
| 57 | MAP2K6 | 1.10822544 |
| 58 | MATK | 1.10536665 |
| 59 | CAMKK1 | 1.09971631 |
| 60 | CAMK1 | 1.08637184 |
| 61 | STK4 | 1.08124241 |
| 62 | PRKCH | 1.07931416 |
| 63 | MAP3K1 | 1.06264165 |
| 64 | CDK7 | 1.06013750 |
| 65 | INSRR | 1.05907144 |
| 66 | NTRK3 | 1.05730881 |
| 67 | MAP3K8 | 1.04078686 |
| 68 | CHEK2 | 1.03746906 |
| 69 | WEE1 | 0.97844485 |
| 70 | CDK8 | 0.97065060 |
| 71 | SCYL2 | 0.96751267 |
| 72 | FGFR4 | 0.95988902 |
| 73 | MAP3K14 | 0.94766194 |
| 74 | ATR | 0.94300298 |
| 75 | TAOK1 | 0.94248932 |
| 76 | LRRK2 | 0.93148358 |
| 77 | PLK3 | 0.92775184 |
| 78 | BTK | 0.92581181 |
| 79 | MAP4K1 | 0.89335868 |
| 80 | MST1R | 0.86758769 |
| 81 | DAPK2 | 0.86755713 |
| 82 | MST4 | 0.85770836 |
| 83 | MAP3K9 | 0.85575683 |
| 84 | TSSK6 | 0.84601608 |
| 85 | EPHA4 | 0.84476633 |
| 86 | MAP2K4 | 0.84405099 |
| 87 | SIK1 | 0.80590284 |
| 88 | EIF2AK3 | 0.79412035 |
| 89 | TGFBR2 | 0.79142041 |
| 90 | MAP3K5 | 0.78965864 |
| 91 | BMPR2 | 0.78765060 |
| 92 | WNK4 | 0.78680686 |
| 93 | KIT | 0.78312008 |
| 94 | RPS6KB2 | 0.78207826 |
| 95 | PDK1 | 0.78195996 |
| 96 | MAPK11 | 0.78076062 |
| 97 | MAP3K11 | 0.77718958 |
| 98 | MOS | 0.76385184 |
| 99 | BRAF | 0.76383736 |
| 100 | TEC | 0.75367563 |
| 101 | CDK6 | 0.74107465 |
| 102 | TNK2 | 0.74000109 |
| 103 | PRKD3 | 0.72560385 |
| 104 | KSR1 | 0.71202580 |
| 105 | CDK4 | 0.70530578 |
| 106 | EIF2AK2 | 0.70406144 |
| 107 | PIK3CG | 0.69963130 |
| 108 | DYRK3 | 0.68342328 |
| 109 | ACVR1B | 0.68010037 |
| 110 | RET | 0.67730584 |
| 111 | NEK9 | 0.66898621 |
| 112 | CSNK1G3 | 0.66736410 |
| 113 | DAPK3 | 0.65395245 |
| 114 | JAK2 | 0.65231291 |
| 115 | SMG1 | 0.64202123 |
| 116 | HIPK2 | 0.64106988 |
| 117 | ZAK | 0.62124699 |
| 118 | BRSK2 | 0.60619130 |
| 119 | MAPKAPK5 | 0.60509008 |
| 120 | IRAK2 | 0.60421174 |
| 121 | CLK1 | 0.58616788 |
| 122 | MAP2K2 | 0.58142112 |
| 123 | ERBB3 | 0.57974290 |
| 124 | BRSK1 | 0.57919559 |
| 125 | MAP3K3 | 0.57433113 |
| 126 | BLK | 0.56865515 |
| 127 | TGFBR1 | 0.56801927 |
| 128 | NEK2 | 0.55777655 |
| 129 | TYK2 | 0.54269946 |
| 130 | MAP3K2 | 0.54230275 |
| 131 | IRAK4 | 0.53854291 |
| 132 | ILK | 0.53741321 |
| 133 | CHEK1 | 0.53519727 |
| 134 | PRKAA2 | 0.52029206 |
| 135 | FES | 0.51492477 |
| 136 | JAK3 | 0.51081552 |
| 137 | MAPK4 | 0.50748837 |
| 138 | TBK1 | 0.50460014 |
| 139 | SYK | 0.50094668 |
| 140 | PAK1 | 0.49547934 |
| 141 | CDK14 | 0.47430216 |
| 142 | CAMK2G | 0.46258582 |
| 143 | CSNK2A1 | 0.45521905 |
| 144 | PDPK1 | 0.44871842 |
| 145 | PASK | 0.44313638 |
| 146 | CSNK1G1 | 0.43993866 |
| 147 | AKT2 | 0.43099295 |
| 148 | TAOK2 | 0.42703840 |
| 149 | CDK9 | 0.41978242 |
| 150 | CSNK1A1L | 0.41800614 |
| 151 | MAP2K1 | 0.40825605 |
| 152 | CSNK2A2 | 0.39496623 |
| 153 | PRKD1 | 0.39131896 |
| 154 | CAMK4 | 0.38823344 |
| 155 | NME1 | 0.37240729 |
| 156 | CSF1R | 0.36369276 |
| 157 | IKBKB | 0.35979428 |
| 158 | PRKACG | 0.35970805 |
| 159 | CDK5 | 0.35645547 |
| 160 | CDK15 | 0.35640554 |
| 161 | IKBKE | 0.34809162 |
| 162 | STK38 | 0.34731396 |
| 163 | RPS6KA5 | 0.34725266 |
| 164 | KDR | 0.34271376 |
| 165 | ATM | 0.33948017 |
| 166 | GRK6 | 0.33493624 |
| 167 | CDK11A | 0.33002590 |
| 168 | CDK18 | 0.32372062 |
| 169 | PRPF4B | 0.32316860 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.18168729 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.60873984 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.45635759 |
| 4 | Base excision repair_Homo sapiens_hsa03410 | 3.39249001 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.30029832 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.24729755 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 3.23713064 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.13901326 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.81011984 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.76287071 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.64990305 |
| 12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.34167264 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.33961704 |
| 14 | Carbon metabolism_Homo sapiens_hsa01200 | 2.25134617 |
| 15 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.16276425 |
| 16 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.15309138 |
| 17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.12840183 |
| 18 | Spliceosome_Homo sapiens_hsa03040 | 2.10961670 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.04034462 |
| 20 | Homologous recombination_Homo sapiens_hsa03440 | 1.99952486 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.96729278 |
| 22 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.94898864 |
| 23 | Parkinsons disease_Homo sapiens_hsa05012 | 1.89664538 |
| 24 | RNA polymerase_Homo sapiens_hsa03020 | 1.88625356 |
| 25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.88497187 |
| 26 | Ribosome_Homo sapiens_hsa03010 | 1.86865824 |
| 27 | Cell cycle_Homo sapiens_hsa04110 | 1.86167500 |
| 28 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.77053688 |
| 29 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.76046487 |
| 30 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.75062826 |
| 31 | Peroxisome_Homo sapiens_hsa04146 | 1.72642735 |
| 32 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.69698031 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.68587434 |
| 34 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.62574609 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.57517270 |
| 36 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.56231830 |
| 37 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.54996403 |
| 38 | RNA transport_Homo sapiens_hsa03013 | 1.52374149 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.51455082 |
| 40 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.49355345 |
| 41 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.46314113 |
| 42 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.42056587 |
| 43 | Sulfur relay system_Homo sapiens_hsa04122 | 1.40862914 |
| 44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.38730528 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.33312371 |
| 46 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.25960056 |
| 47 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.24290027 |
| 48 | Alzheimers disease_Homo sapiens_hsa05010 | 1.22934084 |
| 49 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.19606075 |
| 50 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.19183180 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18600496 |
| 52 | Purine metabolism_Homo sapiens_hsa00230 | 1.16946347 |
| 53 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.16566366 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.14070502 |
| 55 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.13521342 |
| 56 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.11137526 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 1.11104799 |
| 58 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.08517920 |
| 59 | Bile secretion_Homo sapiens_hsa04976 | 1.06724956 |
| 60 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.03946356 |
| 61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02900005 |
| 62 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.00884872 |
| 63 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.98909522 |
| 64 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.97081592 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.94117048 |
| 66 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.93515450 |
| 67 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.93260153 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.93260012 |
| 69 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.92621200 |
| 70 | * Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.92318754 |
| 71 | Shigellosis_Homo sapiens_hsa05131 | 0.91350306 |
| 72 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.90959113 |
| 73 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.90326699 |
| 74 | Huntingtons disease_Homo sapiens_hsa05016 | 0.86929224 |
| 75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86133959 |
| 76 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.84128958 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83994054 |
| 78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.82796526 |
| 79 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.80782389 |
| 80 | DNA replication_Homo sapiens_hsa03030 | 0.80449775 |
| 81 | Legionellosis_Homo sapiens_hsa05134 | 0.80167035 |
| 82 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.79830432 |
| 83 | RNA degradation_Homo sapiens_hsa03018 | 0.77928233 |
| 84 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.74789744 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.72973279 |
| 86 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.72321692 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72280683 |
| 88 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72251666 |
| 89 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.71357557 |
| 90 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.70847961 |
| 91 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.69638170 |
| 92 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.69477643 |
| 93 | Viral myocarditis_Homo sapiens_hsa05416 | 0.69289379 |
| 94 | Insulin secretion_Homo sapiens_hsa04911 | 0.68563243 |
| 95 | Protein export_Homo sapiens_hsa03060 | 0.67453432 |
| 96 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66925643 |
| 97 | Lysosome_Homo sapiens_hsa04142 | 0.63202456 |
| 98 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.63171494 |
| 99 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.62885296 |
| 100 | Histidine metabolism_Homo sapiens_hsa00340 | 0.62698203 |
| 101 | Leishmaniasis_Homo sapiens_hsa05140 | 0.61046191 |
| 102 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.59811492 |
| 103 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.57309727 |
| 104 | Bladder cancer_Homo sapiens_hsa05219 | 0.56733352 |
| 105 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56379558 |
| 106 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55930134 |
| 107 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.55322758 |
| 108 | Asthma_Homo sapiens_hsa05310 | 0.55102635 |
| 109 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.54185544 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.52624705 |
| 111 | Circadian entrainment_Homo sapiens_hsa04713 | 0.52432708 |
| 112 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50931629 |
| 113 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49233754 |
| 114 | Basal transcription factors_Homo sapiens_hsa03022 | 0.49122011 |
| 115 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.48922635 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47603233 |
| 117 | Lysine degradation_Homo sapiens_hsa00310 | 0.46508006 |
| 118 | Salmonella infection_Homo sapiens_hsa05132 | 0.46231987 |
| 119 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.45924560 |
| 120 | Other glycan degradation_Homo sapiens_hsa00511 | 0.45180217 |
| 121 | Apoptosis_Homo sapiens_hsa04210 | 0.44799356 |
| 122 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.44017805 |
| 123 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43503596 |
| 124 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.42228691 |
| 125 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.41838531 |
| 126 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.40796610 |
| 127 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.39438978 |
| 128 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.39135322 |
| 129 | Phagosome_Homo sapiens_hsa04145 | 0.39096566 |
| 130 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37597162 |
| 131 | Tuberculosis_Homo sapiens_hsa05152 | 0.36894082 |
| 132 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.36715133 |
| 133 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.36310213 |
| 134 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.36269480 |
| 135 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35932897 |
| 136 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.35446601 |
| 137 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.33908898 |
| 138 | Retinol metabolism_Homo sapiens_hsa00830 | 0.33772315 |
| 139 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.33682636 |
| 140 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.32396636 |
| 141 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.32345648 |
| 142 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.32252533 |
| 143 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.30194263 |
| 144 | Long-term potentiation_Homo sapiens_hsa04720 | 0.29925497 |
| 145 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.28792543 |
| 146 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28746277 |
| 147 | Thyroid cancer_Homo sapiens_hsa05216 | 0.28272343 |
| 148 | Salivary secretion_Homo sapiens_hsa04970 | 0.28243148 |
| 149 | Olfactory transduction_Homo sapiens_hsa04740 | 0.25848457 |
| 150 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.24506188 |
| 151 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.24009339 |
| 152 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.22515140 |
| 153 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.21297050 |
| 154 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.20482962 |
| 155 | Renin secretion_Homo sapiens_hsa04924 | 0.20266769 |
| 156 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.18652491 |

